Radient Technologies Inc. filing application for Controlled Drugs and Substances Dealers license to serve the Cannabinoids Medical Market
(firmenpresse) - EDMONTON, ALBERTA -- (Marketwired) -- 11/14/16 -- Radient Technologies Inc. ("Radient" or the "Company") (TSX VENTURE: RTI), with its proprietary Microwave-Assisted Processing (MAP™) technology and, its related expertise in natural product extraction, purification and isolation, is pleased to announce its foray in the fast emerging cannabinoids medical market. Radient''s MAP™ technology has applications across a wide range of industry verticals, which includes pharmaceuticals, nutritional supplements, food and beverage, cosmetics, tobacco and now - of increasing relevance - the fast growing cannabinoids market.
Radient is currently taking advantage of its superior extraction technology to establish itself as a leading North American player, capturing value in the medical cannabinoids market extracted from both marijuana and hemp. There is a latent need to extract cannabinoids with a higher efficiency and purity to create value and meet strict Quality Assurance standards as the regulatory environment changes.
Radient, with its unique MAP™ technology, has the potential to supply the cannabinoids industry with hemp extracts standardized to specific concentrations of cannabinoids while meeting regulatory standards with less than 0.3% tetrahydrocannabinol (THC). Further, Radient''s full-scale, GMP-certified facility will allow the Company to easily capitalize on the industry''s desire to partner with a reputable extraction expert to offer product manufacturing under strict Quality Assurance and Quality Control while possessing the capacity necessary to meet growing demand for standardized hemp extracts and marijuana concentrates.
As a part of these regulatory changes and demand pressures, Radient has requested proper accreditation and permits from the Canadian Government for conducting research and the eventual commercial production of standardized cannabinoids extracts. The Company''s application for a Controlled Drugs and Substances Dealers license is currently being prepared for submission and will be followed by partnerships with leading suppliers of hemp and marijuana biomass.
Radient will be participating at the Canadian Hemp Trade Alliance (CHTA) Conference in Saskatoon and the Marijuana Business Conference & Expo in Las Vegas both during the week of November 14 to meet with potential suppliers and customers.
About Radient
Radient extracts natural compounds from a range of biological materials using microwave assisted processing ("MAP™"), a patented technology platform which provides superior customer outcomes in terms of ingredient purity, yield, and cost. From its 20,000 square foot manufacturing plant in Edmonton, Alberta, Radient serves market leaders in industries that include pharmaceutical, food, beverage, natural health, personal care and biofuel markets. Visit for more information.
Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
Contacts:
Denis Taschuk
Chief Executive Officer
(780) 465-1318
Prakash Hariharhan
Chief Financial Officer
(780) 465-1318
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
Datum: 14.11.2016 - 08:00 Uhr
Sprache: Deutsch
News-ID 1469728
Anzahl Zeichen: 2956
contact information:
Contact person:
Town:
EDMONTON, ALBERTA
Phone:
Kategorie:
Software
Typ of Press Release:
type of sending:
Date of sending:
Anmerkungen:
Diese Pressemitteilung wurde bisher 177 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Radient Technologies Inc. filing application for Controlled Drugs and Substances Dealers license to serve the Cannabinoids Medical Market
"
steht unter der journalistisch-redaktionellen Verantwortung von
Radient Technologies Inc. (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
